NCT00574496 2023-09-28
Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Eastern Cooperative Oncology Group
Centre for Human Drug Research, Netherlands
Rochester Skin Lymphoma Medical Group, PLLC
Stanford University
National Cancer Institute (NCI)